Financial statements Drogmap
Balance sheet of Drogmap
Company age:
Age:
3 y. 2 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of DROGMAP
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 108 537,81 | 259 586,13 |
| A. Fixed assets | 0,00 | 0,00 |
| B. Current assets | 108 537,81 | 211 658,40 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 108 537,81 | 259 586,13 |
| A. Equity | 7 625,37 | 40 966,76 |
| B. Liabilities and provisions for liabilities | 100 912,44 | 218 619,37 |
| I. Long-term liabilities | 0,00 | - |
| II. Short-term liabilities | 98 631,86 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.